A
ARVEE
vs
B
BSE Sensex 30
Over the past 12 months, ARVEE has outperformed BSE Sensex 30, delivering a return of +18% compared to the BSE Sensex 30's +11% growth.
Stocks Performance
ARVEE vs BSE Sensex 30
Performance Gap
ARVEE vs BSE Sensex 30
Performance By Year
ARVEE vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Arvee Laboratories (India) Ltd
Glance View
Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-02-22. The firm is primarily engaged in the manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers include 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates include 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic acid. Its Drug Intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
